FYERS
Biofil Chemicals & Pharmaceuticals30.43
+0.32 (+1.06%)

Biofil Chemicals & Pharmaceuticals Share Price

30.43+0.32 (+1.06%)
-25.80% past 1 Year

Corporate filings & documents

Announcements

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th September 2026
1 day ago
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th September 2026
1 day ago
Intimation of closure of Trading window with effect from Thursday 01st October 2026
1 week ago
Intimation of closure of Trading window with effect from Thursday 01st October 2026
1 week ago
Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Non- executive Independent Director of the company upon attaining the age of 75 (seventy-five) years.
1 week ago
Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Non- executive Independent Director of the company upon attaining the age of 75 (seventy-five) years.
1 week ago
Scruitinizer report with voting results
1 week ago
Scruitinizer report with voting results
1 week ago
Summary of Proceedings of 41st Annual General Meeting of the company held on Wednesday 23rd September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 weeks ago
Summary of Proceedings of 41st Annual General Meeting of the company held on Wednesday 23rd September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 weeks ago
Pursuant to Regulation 30 44 and 47 of SEBI(LODR) Regulations 2015 and in compliance with Section 108 of the Companies Act 2013 read with rule 20 of Companies (Management and Administration) Rules 2014 we enclosed herewith extract of newspaper published on 28th August 2026 in Free Press Mumbai (English) Free Press Indore (English) and Choutha Sansar (Hindi) edition.
1 month ago
Pursuant to Regulation 30 44 and 47 of SEBI(LODR) Regulations 2015 and in compliance with Section 108 of the Companies Act 2013 read with rule 20 of Companies (Management and Administration) Rules 2014 we enclosed herewith extract of newspaper published on 28th August 2026 in Free Press Mumbai (English) Free Press Indore (English) and Choutha Sansar (Hindi) edition.
1 month ago
Information under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and Section 108 of the Companies Act 2013 regarding voting through electronic mode for the 41st Annual General Meeting scheduled to be held on Wednesday 23rd September 2026
1 month ago
Information under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and Section 108 of the Companies Act 2013 regarding voting through electronic mode for the 41st Annual General Meeting scheduled to be held on Wednesday 23rd September 2026
1 month ago
Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ depository participants
1 month ago
Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ depository participants
1 month ago
Submission of Integrated Annual Report for the Financial Year 2025-26 along with Notice convening the 41st Annual General Meeting as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month ago
Submission of Integrated Annual Report for the Financial Year 2025-26 along with Notice convening the 41st Annual General Meeting as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month ago
Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio-visual means (OAVM)
1 month ago
Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio-visual means (OAVM)
1 month ago
Newspaper publication of Notice of 41st AGM through Video Conferencing (VC)/ Other Audio Visual Means (OAVM)
1 month ago
Newspaper publication of Notice of 41st AGM through Video Conferencing (VC)/ Other Audio Visual Means (OAVM)
1 month ago
Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
1 month ago
Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
1 month ago
Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company notwithstanding his attaining the age of 75 (Seventy Five )Years
1 month ago
Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company notwithstanding his attaining the age of 75 (Seventy Five )Years
1 month ago
Un-Audited Financial Results for the quarter ended 30th June 2026
1 month ago
Un-Audited Financial Results for the quarter ended 30th June 2026
1 month ago
Outcome of Board Meeting held on Tuesday 11th August 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
1 month ago
Outcome of Board Meeting held on Tuesday 11th August 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
1 month ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June 2026 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair.
2 months ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June 2026 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair.
2 months ago
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th June 2026.
3 months ago
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018 for the quarter ended 30th June 2026.
3 months ago
Closure of Trading Window for the quarter ended 30.06.2026
3 months ago
Closure of Trading Window for the quarter ended 30.06.2026
3 months ago
Submission of publication of Audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
4 months ago
Submission of publication of Audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015
4 months ago
Audited Financial Result for the Financial Year ended 31.03.2026
4 months ago
Outcome of Board Meeting held on Saturday 30th May 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
4 months ago
Outcome of Board Meeting held on Saturday 30th May 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
4 months ago
Submission of Annual Secretarial Compliance Report for the Financial year ended 31st March 2026
4 months ago
Submission of Annual Secretarial Compliance Report for the Financial year ended 31st March 2026
4 months ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the fourth Quarter as well as Financial Year ended on 31st March 2026.
4 months ago
Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the fourth Quarter as well as Financial Year ended on 31st March 2026.
4 months ago
The Company hereby submit drafts intimation letter sent to holders of Physical shares of the company for updating PAN KYC Nomination and other details in accordance with applicable SEBI Circulars in terms of provisions of Reg.30 of SEBI (LODR) Regulations 2015 from time to time.
5 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Biofil Chemicals & Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.02</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Apoorv Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 10/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
6 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Biofil Chemicals & Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.02</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Apoorv Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 10/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
6 months ago
Submission of Publication in Newspaper pursuant to SEBI circular for Special Window for Transfer and Dematerialisation of Physcial Securities.
6 months ago
Submission of Publication in Newspaper pursuant to SEBI circular for Special Window for Transfer and Dematerialisation of Physcial Securities.
6 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Biofil Chemicals & Pharmaceuticals Ltd Share Price Today

The Biofil Chemicals & Pharmaceuticals Ltd share price today is ₹29.38. During the trading session, the Biofil Chemicals & Pharmaceuticals Ltd share price opened at ₹30.4 and recorded an intraday high of ₹30.73 and a low of ₹29.01. Last closing price was ₹30.38. Over the past 52 weeks, the Biofil Chemicals & Pharmaceuticals Ltd share price has ranged between ₹25.6 and ₹46.34. The current Biofil Chemicals & Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.